Insight

Jul 14, 2025, 18:17

An Overview and Guide for Patients by ALK-Positive NSCLC Patients and Medical Experts

A paper by Nancee Pronsati et al. (Patient Author from Colorado), published in Lung Cancer, was mentioned by Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, on X:

Title: Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts

Authors: Nancee Pronsati, Geoffrey Liu, Todd M. Bauer, Enriqueta Felip, Yasushi Goto, Gerald Green, Mary Grizzard, Michael Hamel, Julien Mazieres, Tony Mok, Stephanie Snow, Benjamin J. Solomon, Jan Stratmann, Ken Culver.

You can read the Full Article in Lung Cancer.

More posts featuring Praveen Kumar Marimuthu.

ALK-positive NSCLC Benjamin J. Solomon cancer Enriqueta Felip Geoffrey Liu Gerald Green Jan Stratmann Julien Mazières Ken Culver lorlatinib Lung cancer Mary Grizzard Michael Hamel Nancee Pronsati NSCLC OncoDaily Oncology Praveen Kumar Marimuthu Stephanie Snow Todd M Bauer Tony Mok Yasushi Goto

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark